Susan Manners has a BSc (Hons) UNSW. She teaches fundamental science content and laboratory classes in the MPharm degree at UTS.

In addition to 3 years in research at St. George Hospital, she has spent 1 year in industry as an Analyst, with York Bioanalytical Solutions, York, UK (2006), and with NaturaLab, Sydney (2008), and 2 years in research support and laboratory management with The University of Sydney (2009-2010).

Past areas of research:

Pharmacokinetics of chemotherapeutic agent gemcitabine Crystallisation and stability of gemcitabine Genotype influence on gemcitabine metabolism and therapeutic effect

Metharom, E., Galettis, P., Manners, S., Jelinek, M., Liauw, W., de SOUZA, P. L., Hoskins, J.M. & Links, M. (2011). The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c. 79A> C. Asia?Pacific Journal of Clinical Oncology, 7(1), 65-74. Manners, S., Galettis, P., & de Souza, P. (2011). Conditions causing gemcitabine crystallization. Journal of Oncology Pharmacy Practice, 17(4), 395-399. Metharom, E., Galettis, P., Manners, S., & Links, M. (2010). Modulation of gemcitabine accumulation by DNA-damaging agents: mechanisms and specificity in an in vitro model. Anticancer research, 30(9), 3669-3673. Grimison, P., Galettis, P., Manners, S., Jelinek, M., Metharom, E., de Souza, P. L., Liauw, W. & Links, M. J. (2007). Randomized crossover study evaluating the effect of gemcitabine infusion dose rate: evidence of auto-induction of gemcitabine accumulation. Journal of Clinical Oncology, 25(36), 5704-5709.